Market Instability Calls for Biopharma Leaders
"Policy changes and market forces cause uncertainty in clinical research and development. Analysts highlight GLP-1 inhibitors' market potential and tariff impacts."
Browsing Tag
r&d
Medicaid Prescription Costs Rise Despite Less Usage
TL/DR -
Despite lower utilization of prescription medications, Medicaid spending on prescription drugs has…
Overcoming Obstacles to Affordable Healthcare: A Guide
TL/DR -
A recent survey by PhRMA reveals that having health insurance doesn't always guarantee optimal healthcare…